Alferink, M. T.
Moreno-Sanz, B.
Cabrera-Lafuente, M.
Ergenekon, E.
de Haan, T. R.
van Kempen, A. A. M. W.
Lakhwani, J.
Rabe, H.
Zaharie, G. C.
Pellicer, A.
,
Funding for this research was provided by:
Horizon 2020 Framework Programme (101007922)
Article History
Received: 4 January 2024
Accepted: 8 March 2024
First Online: 10 April 2024
Declarations
:
: According to Spanish law, this trial was centrally approved by the Medical Ethics Committee of La Paz University Hospital (Internal code: 2022.343; HULP code: 6236, 29 July 2022). The trial will be conducted in accordance with the principles of the GCP guidelines (CPMP/ICH/135/95), and with the current legislation that regulates its operation. Individual sites received approval from local research ethics boards or quality-improvement committees, as appropriate.
: The Clinical Publication Committee shall deal with all aspects regarding publications that arise from RISEinFAMILY activities. Partners interested in producing RISEinFAMILY publications shall submit a 1–2-page proposal to the CPC for approval.
: The authors declare that they have no competing interests.